Home > Information > News

Lepu Medical Joins Hands with Meituan

Yitong News Agency 2025-09-25 18:53:22

Currently, traditional medical device leaders are re-evaluating their boundaries. Transformation is no longer a choice, but a matter of survival.

Lepu Medical's answer is medical aesthetics. This veteran company, which has been deeply involved in the cardiovascular field for 25 years, has chosen to closely partner with Meituan in an attempt to find a second growth pole in the blue ocean of new consumer healthcare.

September 22nd,Lepu Medical (300003.SZ)Announcement, andHanHai Information Technology (Shanghai) Co., Ltd.Sign the "Strategic Cooperation Agreement," while HanhaiMeituan's core operating entity in Shanghai.。

The core of this strategic collaboration is "complementary and mutually beneficial." Can the combination of the two effectively address each other's shortcomings in the medical aesthetics field?

Inevitably Choosing Amidst Growth Dilemmas

As a leading enterprise in the cardiovascular diagnosis and treatment field in China, Lepu Medical has covered core businesses including medical devices, pharmaceuticals, medical services, and health management since its establishment in 1999.

As of June this year, 2,374 patents have been applied for, and there are 687 Class II and III medical device registration certificates.Long-term leading position in the field of cardiovascular interventional devices.。

In recent years, this established medical company has faced significant challenges in its performance due to the ongoing impact of centralized procurement policies, goodwill impairment, and multiple pressures.

The company's financial report shows that in the first half of 2025, Lepu Medical's revenue was 3.37 billion yuan, a slight decrease of 0.4% year-on-year; the net profit attributable to the parent company was 691 million yuan, down 0.9% year-on-year. Although the decline is limited, such performance undoubtedly serves as a wake-up call for a once fast-growing leader in the medical device industry.

In this context, finding new tracks has become a necessity. The medical aesthetics industry, with its high prosperity and consumer attributes, naturally enters Lepu's vision.

Leveraging its technical expertise in biodegradable materials and biomedical engineering, Lepu has established a comprehensive framework."Young Face Needle - Hyaluronic Acid - Botox"Three major mainstay medical beauty product lines.

In June of this year, independently developedPolylactic acid facial filler ("baby face injection") approved for market launch.It has become the seventh of its kind in the country and the fifth domestically produced product.

In addition, sodium hyaluronate solution for injection.Approved.Cross-linked sodium hyaluronate gel, sodium hyaluronate composite solutionEnter the declaration and registration stage.

Subsidiary Lepu Jiantang's applicationRecombinant Botulinum Toxin Type A for InjectionIn May 2025, it was also accepted by the CDE, aiming at the domestic market.6 billion yuanThe scale of the botulinum toxin market.

Lepu Medical Beauty products are available, and channels have become key.

This collaboration with HanHai InformationThe core objective is to accelerate the commercialization of these products.

▍Meituan's traffic password

In the medical aesthetics industry, channel effectiveness often directly determines the fate of products. Aimeike's "Moist White Angel" youth injection achieved sales of over 1 billion yuan in its first year on the market, thanks to mature channels; East China Pharmaceutical's "Youth Injection" also quickly entered the commonly used list in institutions with the support of channels.

Han Hai Information, established in March 2006, is essentially the core operating entity of Meituan in Shanghai.

What we use in our daily lives.Meituan, DianpingThe legal operating rights are entirely in its hands, which means it can directly mobilize the core resources of the Meituan ecosystem.

Meituan's value lies in its scale and precision. Relying on Meituan."Retail + Technology"The strategy is that Han Hai Information can mobilize resources that cover all online and offline scenarios.

Online,Meituan, Dianping, and other app services More than 200Category, covering the whole country.More than 2800County, city, district, and banner, with a massive user base and the ability to achieve precise marketing through big data.

From the perspective of traffic scale, Meituan's medical beauty channel will have over ten million daily active users in 2024, and the transaction scale related to medical beauty surpassed 50 billion yuan in 2023, indicating a solid user base.

OfflineMeituan's local life service network can connect medical beauty institutions and offline stores to form"Online Traffic - Offline Experience"The closed loop.

Cooperation for mutual benefit, reshaping boundaries.

The announcement shows that both parties have signedStrategic Cooperation AgreementIt does not remain at the simple level of "supply-sales," but rather connects.Brand operation, product distribution, marketing collaborationForm a complete cooperation chain.

According to the agreement between both parties, HanHai Information has obtained the exclusive distribution and operation rights for the two major brands "Yueya Yan" and "Flora" in mainland China.

The essence of cooperation is reflected on three levels:

At the brand authorization level, Hanhai is fully responsible for the distribution and market operation of the two brand series products, ensuring that Lepu Medical Beauty products are prominently featured on the platform.

In terms of marketing collaboration, both parties jointly formulate sales and promotion strategies. Meituan is responsible for online advertising and offline store coordination, while Lepu provides clinical support and professional training, achieving a combination of professionalism and communication effectiveness.

In terms of service co-construction, both parties jointly maintain user experience and reputation in the after-sales phase to ensure long-term repurchase rates.

The imagination space for cooperation is not limited to already listed products. The agreement, in the future, both parties can gradually expand to Lepu's other medical aesthetic pipelines, reserving channels for the subsequent launch of new botulinum toxin and hyaluronic acid products.

The key value of this collaboration lies in complementing the medical aesthetics business of Lepu Medical."Online Shortcomings"。

Previously, Lepu's sales network was mainly offline, covering the entire country.Over 9,000 companiesMedical institutions (including more than 3,000 hospitals capable of performing PCI surgery) andMore than 360,000 businessesThe retail pharmacy, however, lacks significant experience in consumer-end online traffic operations required for medical aesthetics.

The addition of Han Hai Information is expected to completely change the situation.

For Lepu Medical, which is under performance pressure, this cooperation with Hanhai Information is not only a breakthrough on the channel side but also a significant advancement."Innovation + Consumption"The key step in the implementation of the strategy. One of the core barriers in the medical beauty industry is..."Channels and Brands"Meituan's ecosystem happens to provide these two major supports for Lepu.

Lepu's "Tong Yan Zhen" (Youthful Appearance Injection), as the fifth domestic product of its kind to be approved, is expected to reach more consumers and medical aesthetics institutions through Meituan's channel."Sales increase upon launch"Injecting key momentum for performance growth after 2026.

The deeper significance of the cooperation between both parties lies in Lepu Medical.The transition from "traditional medical devices" to "consumer healthcare"Made a substantial step forward.

The partnership between Lepu Medical and Meituan is a deep trial between a traditional medical leader and an internet giant. This is not only expected to open new growth avenues for Lepu but also reflects the ongoing boundary reshaping across the entire medical industry.

【Copyright and Disclaimer】The above information is collected and organized by PlastMatch. The copyright belongs to the original author. This article is reprinted for the purpose of providing more information, and it does not imply that PlastMatch endorses the views expressed in the article or guarantees its accuracy. If there are any errors in the source attribution or if your legitimate rights have been infringed, please contact us, and we will promptly correct or remove the content. If other media, websites, or individuals use the aforementioned content, they must clearly indicate the original source and origin of the work and assume legal responsibility on their own.

Lepu Medical Joins Hands with Meituan

Most Popular